HIGH GRADE EPITHELIAL OVARIAN CANCER
Clinical trials for HIGH GRADE EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH GRADE EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Rina-S shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, Rina-S, in people with advanced solid tumors that have spread or can't be removed by surgery. The goal is to see if Rina-S is safe and how well it works against cancers like ovarian, lung, and breast cancer. About 884 participants will receive the dru…
Matched conditions: HIGH GRADE EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New trial tests drug combo to keep ovarian cancer at bay
Disease control Recruiting nowThis study is for women with advanced ovarian cancer who have had complete surgery and chemotherapy. It compares two maintenance treatments: niraparib alone versus niraparib plus bevacizumab. The goal is to see which approach better delays cancer progression. About 390 participan…
Matched conditions: HIGH GRADE EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study tracks ovarian cancer care in real life
Knowledge-focused Recruiting nowThis study follows 750 women with advanced ovarian cancer in Germany to see how they are treated in real-world settings. It focuses on the use of PARP inhibitor maintenance therapy after chemotherapy and how it affects outcomes and quality of life. The goal is to learn what works…
Matched conditions: HIGH GRADE EPITHELIAL OVARIAN CANCER
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC